Genscript Biotech
1548.HK
$2.36
Share price
2.88%
Change (1 day)
49.65%
Change (1 year)
Categories
P/S ratio for Genscript Biotech (1548.HK)
P/S ratio at the end of 2024: 4.60
According to Genscript Biotech 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.19. At the end of 2024 the company had a P/S ratio of 4.60.
P/S ratio history for Genscript Biotech from 2015 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 4.60 | -52.27% |
| 2023 | 9.63 | -10.63% |
| 2022 | 10.8 | -43.18% |
| 2021 | 19.0 | 161.8% |
| 2020 | 7.25 | -53.6% |
| 2019 | 15.6 | 45.77% |
| 2018 | 10.7 | -62.87% |
| 2017 | 28.9 | 315.63% |
| 2016 | 6.94 | 120.88% |
| 2015 | 3.14 |